De-risking the clinical development of cholesteryl ester transfer protein inhibitors: how much is good enough?

被引：6
|
作者：
Arsenault, Benoit J. [2 ]
Boekholdt, S. Matthijs [3 ]
Tardif, Jean-Claude [2 ]
Kastelein, John J. P. [1 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Montreal, Montreal Heart Inst, Quebec City, PQ, Canada
[3] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷 / 13期
关键词：
OFF-TARGET TOXICITY; ENDOTHELIAL DYSFUNCTION; TORCETRAPIB; ALDOSTERONE; DISEASE; SAFETY;
D O I：
10.1093/eurheartj/ehr408
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1548 / 1550
页数：3
相关论文
共 50 条
  • [21] Crystal Structures of Cholesteryl Ester Transfer Protein in Complex with Inhibitors
    Liu, Shenping
    Mistry, Anil
    Reynolds, Jennifer M.
    Lloyd, David B.
    Griffor, Matthew C.
    Perry, David A.
    Ruggeri, Roger B.
    Clark, Ronald W.
    Qiu, Xiayang
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (44) : 37321 - 37329
  • [22] Cholesteryl Ester Transfer Protein (CETP) Deficiency and CETP Inhibitors
    Mabuchi, Hiroshi
    Nohara, Atsushi
    Inazu, Akihiro
    [J]. MOLECULES AND CELLS, 2014, 37 (11) : 777 - 784
  • [23] Present therapeutic role of cholesteryl ester transfer protein inhibitors
    Ferri, Nicola
    Corsini, Alberto
    Sirtori, Cesare R.
    Ruscica, Massimiliano
    [J]. PHARMACOLOGICAL RESEARCH, 2018, 128 : 29 - 41
  • [24] QSAR STUDY OF A SERIES OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS
    Chhabria, Mahesh T.
    Suhagia, Bhanubhai N.
    Mandhare, Appaji B.
    Brahmkshatriya, Pathik S.
    [J]. COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 2011, 76 (07) : 803 - 813
  • [25] Cholesteryl Ester Transfer Protein Inhibitors Future Soon to be REVEALed
    Huggins, Christopher
    Charolidi, Nicoletta
    Cockerill, Gillian W.
    [J]. EUROPEAN CARDIOLOGY REVIEW, 2015, 10 (01) : 64 - 67
  • [26] Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitors
    Eary, C. Todd
    Jones, Zachary S.
    Groneberg, Robert D.
    Burgess, Laurence E.
    Mareska, David A.
    Drew, Mark D.
    Blake, James F.
    Laird, Ellen R.
    Balachari, Devan
    O'Sullivan, Michael
    Allen, Andrew
    Marsh, Vivienne
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (09) : 2608 - 2613
  • [27] Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib
    Goldberg, Alyse S.
    Hegele, Robert A.
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2012, 6 : 251 - 259
  • [28] Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
    Chapman, M. John
    Le Goff, Wilfried
    Guerin, Maryse
    Kontush, Anatol
    [J]. EUROPEAN HEART JOURNAL, 2010, 31 (02) : 149 - 164
  • [29] Update on the Discovery and Development of Cholesteryl Ester Transfer Protein Inhibitors for Reducing Residual Cardiovascular Risk
    Mantlo, Nathan B.
    Escribano, Ana
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (01) : 1 - 17
  • [30] Diphenylpyridylethanamine (DPPE)-based aminoheterocycles as cholesteryl ester transfer protein inhibitors
    Wang, Yufeng
    Yang, Wu
    Finlay, Heather J.
    Harikrishnan, Lalgudi S.
    Jiang, Ji
    Kamau, Muthoni G.
    Van Kirk, Katy
    Nirschl, David S.
    Taylor, David S.
    Chen, Alice Ye A.
    Yin, Xiaohong
    Sleph, Paul G.
    Yang, Richard Z.
    Huang, Christine S.
    Adam, Leonard P.
    Lawrence, R. Michael
    Wexler, Ruth R.
    Salvati, Mark E.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (03) : 860 - 864
12345